J J Brown1, M R Zacharin. 1. Department of Endocrinology and Diabetes, Royal Children's Hospital, Parkville, Victoria, Australia.
Abstract
OBJECTIVES: To describe an attempted interventional trial for glucocorticoid-induced osteoporosis in children and adolescents and to discuss the reasons for trial failure to inform future interventional studies in this important group of patients. METHODS: Prospective randomized controlled trial comparing the effect of bisphosphonate therapy with calcium and vitamin D supplementation on bone mineral accrual is described. For non-trial patients, retrospective analysis of the effect of calcium and vitamin D supplementation combined with bisphosphonate treatment on bone mineral accrual. RESULTS: Only 12 patients were enrolled in the trial over 4 years. Bisphosphonate recipients (n = 5) had a mean annual percentage increase in lumbar spine bone mineral density of 8.76 +/- 5.2% compared to 6.6 +/- 4.0% in the calcium/vitamin-treated group (difference not significant). Mean annual change in lumbar spine areal bone mineral density in non-trial patients (n = 11) was 3.72 +/- 2.5%. CONCLUSION: Conducting a randomized controlled trial in this group of corticosteroid users is difficult, given the unpredictable nature of the underlying disease and intermittent need for steroid treatment. The trial failed through inadequate recruitment combined with discontinued interventions.
RCT Entities:
OBJECTIVES: To describe an attempted interventional trial for glucocorticoid-induced osteoporosis in children and adolescents and to discuss the reasons for trial failure to inform future interventional studies in this important group of patients. METHODS: Prospective randomized controlled trial comparing the effect of bisphosphonate therapy with calcium and vitamin D supplementation on bone mineral accrual is described. For non-trial patients, retrospective analysis of the effect of calcium and vitamin D supplementation combined with bisphosphonate treatment on bone mineral accrual. RESULTS: Only 12 patients were enrolled in the trial over 4 years. Bisphosphonate recipients (n = 5) had a mean annual percentage increase in lumbar spine bone mineral density of 8.76 +/- 5.2% compared to 6.6 +/- 4.0% in the calcium/vitamin-treated group (difference not significant). Mean annual change in lumbar spine areal bone mineral density in non-trial patients (n = 11) was 3.72 +/- 2.5%. CONCLUSION: Conducting a randomized controlled trial in this group of corticosteroid users is difficult, given the unpredictable nature of the underlying disease and intermittent need for steroid treatment. The trial failed through inadequate recruitment combined with discontinued interventions.
Authors: Peter M Wayne; Catherine E Kerr; Rosa N Schnyer; Anna T R Legedza; Jacqueline Savetsky-German; Monica H Shields; Julie E Buring; Roger B Davis; Lisa A Conboy; Ellen Highfield; Barbara Parton; Phaedra Thomas; Marc R Laufer Journal: J Pediatr Adolesc Gynecol Date: 2008-10 Impact factor: 1.814
Authors: Rosa M R Pereira; Mariana O Perez; Ana Patrícia Paula; Caio Moreira; Charlles H M Castro; Cristiano A F Zerbini; Diogo S Domiciano; Elaine de Azevedo; Laura M C Mendonca; Marcia Midore Shinzato; Marco Antonio A da Rocha-Loures; Sebastião Radominski; Vera L Szejnfeld Journal: Arch Osteoporos Date: 2021-03-01 Impact factor: 2.617
Authors: L Ward; A C Tricco; P Phuong; A Cranney; N Barrowman; I Gaboury; F Rauch; P Tugwell; D Moher Journal: Cochrane Database Syst Rev Date: 2007-10-17
Authors: Deborah Buck; Elaine McColl; Christine J Powell; Jing Shen; John Sloper; Nick Steen; Robert Taylor; Peter Tiffin; Luke Vale; Michael P Clarke Journal: Trials Date: 2012-10-16 Impact factor: 2.279
Authors: Madeleine Rooney; Nick Bishop; Joyce Davidson; Michael W Beresford; Clarissa Pilkington; Janet Mc Donagh; Sue Wyatt; Janet Gardner-Medwin; Rangaraj Satyapal; Jacqui Clinch; Helen Foster; Mark Elliott; Rejina Verghis Journal: EClinicalMedicine Date: 2019-07-03